Atossa Therapeutics
ATOS
ATOS
56 hedge funds and large institutions have $15.8M invested in Atossa Therapeutics in 2022 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 7 increasing their positions, 23 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
70% less repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 23
77% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 22
Holders
56
Holding in Top 10
–
Calls
$1.25M
Puts
$971K
Top Buyers
| 1 | +$102K | |
| 2 | +$69.6K | |
| 3 | +$57.3K | |
| 4 |
TSS
Two Sigma Securities
New York
|
+$24.5K |
| 5 |
Group One Trading
Chicago,
Illinois
|
+$21.4K |
Top Sellers
| 1 | -$866K | |
| 2 | -$837K | |
| 3 | -$676K | |
| 4 |
D.E. Shaw & Co
New York
|
-$496K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$211K |